The Food and Drug Administration is considering allowing pharmaceutical makers to provide doctors with medical journal studies of unapproved uses for drugs. Critics say the move would undermine long-standing restrictions on marketing medicines for "off-label" purposes.
Trending:
FDA considers easing curbs on drug makers